Version history
myFibroScan
34
ASO score
Text
39/100
Reviews
0/100
Graphic
60/100
Other
0/100
App Rating
3.9
Votes
23
App Age
8y 8m
Last Update
Nov 04, 2025
Compare with Category Top Apps
|
Metrics
|
Current App
|
Category Top Average
|
Difference
|
|---|---|---|---|
|
Rating
|
3.25
|
4.6
|
-29%
|
|
Number of Ratings (Voted)
|
4
|
66K
|
-100%
|
|
App Age
|
8y 8m
|
9y 5m
|
-8%
|
|
In-app Purchases Price
|
$0
|
$37
|
|
|
Update Frequency
|
49d
|
92d
|
-47%
|
|
Title Length
|
11
|
25
|
-56%
|
|
Subtitle Length
|
25
|
25
|
|
|
Description Length
|
2 247
|
2 724
|
-18%
|
|
Number of Screenshots
|
1404
|
1390
|
+1
%
|
|
Size
|
40MB
|
280MB
|
-86
%
|
Category Ranking in United States
7 days
Last 7 days
Last 30 days
Last 90 days
Last 180 days
Last year
| Top | Dec 16, 2025 | Dec 23, 2025 |
|---|---|---|
|
No results were found!
|
||
| Top | Dec 16, 2025 | Dec 23, 2025 |
|---|---|---|
|
No results were found!
|
||
| Top | Dec 16, 2025 | Dec 23, 2025 |
|---|---|---|
|
No results were found!
|
||
| Top | Dec 16, 2025 | Dec 23, 2025 |
|---|---|---|
|
No results were found!
|
||
Ranking Keywords in United States
| Keywords | App Rank |
|---|
Analyze this and other apps using Asolytics tools
Text ASO
Title
(
Characters:
11
of 30
)
myFibroScan
Subtitle
(
Characters:
25
of 30
)
Your FibroScan® companion
Description
(
Characters:
2247
of 4000
)
FibroScan® is the non-invasive gold standard solution for comprehensive management of liver health.
FibroScan® is powered by three unique, patented and validated biomarkers, LSM by VCTE™ (Liver Stiffness Measurement) and CAP™ (Controlled Attenuation Parameter) that benefit from a worldwide clinical evidence with over 5300+ peer-reviewed publications and 180+ international guidelines.
myFibroScan app is your everyday FibroScan® companion to access Interpretation Guide and FibroScan® based scores in an easy, fast and intuitive way :
The Interpretation Guide utilizes data from clinical studies to assist providers in interpreting FibroScan® examination results.
Scores enhance FibroScan® liver disease assessment with biological markers.
Scores are presented as educational services intended for licensed healthcare professionals. While the scores are about specific medical and healthcare issues, they are not a substitute for/or replacement of personalized medical advice and are not intended to be used as the sole basis for making individualized medical or health-related decisions.
• Fast is an aid to identify at risk MASH patients defined as MASH + NAS≥4 + F≥2. Good to excellent performance in cohorts from different clinical settings (MASLD tertiary care unit, screening, bariatric surgery) and geographical origins (USA, Europe, Asia). Several publications advocate the use of Fast.
• Agile 3+ is an aid to identify MASLD patients with advanced fibrosis by combining LSM by VCTE™ and routine clinical parameters to reduce the need for liver biopsy. High clinical performances are demonstrated in large external validation cohorts from different geographical origins.
• Agile 4 is an aid to early identify MASLD patients with cirrhosis by combining LSM by VCTE™ and routine clinical parameters. It can help the physicians to manage the disease to prevent liver-related complications such as hepatocellular carcinoma. High clinical performances are demonstrated in large external validation cohorts from different geographical origin.
MASH Treatment Eligibility Tool to eliminate the Guesswork.
This patient management tool embeds treatment recommendations based on the patient’s FibroScan® results and the latest AASLD Guidance.}
Read more
Other
Additional Information
| Rating: | |
| Voted: | 23 |
| App Store Link: | |
| Website: | |
| Email: | - |
| Privacy Policy: | |
| Categories: | Medical |
| Size: | 39MB |
| App Age: | 8 years 8 months |
| Release Date: | Apr 16, 2017 |
| Last Update: | Nov 04, 2025 |
| Version: | 2.5.0 |
Version history
2.5.0
Nov 04, 2025
myFibroScan, your Everyday FibroScan® Companion, evolves to bring you:
• Updated Clinical References: The Interpretation Guide now includes the most recent publications, ensuring the tool reflects the latest clinical knowledge.
• Translated in Italian in addition to the existing English, French and German version
2.4.0
Apr 19, 2024
Technological update with new development framework